ABSTRACT Mesothelioma is a slow-growing insidious lesion of neoplastic aetiology arising from the pleural, peritoneal or pericardial mesothelium. It shows a predilection for the surfaces of the pelvic viscera and has a high rate of recurrence after excision. Cystic mesotheliomas are not associated with asbestos exposure. We report a case of cystic mesothelioma of the peritoneum encasing the ovary, which presented as a cystic adnexal mass. As highlighted in this case and other recent reports, a cystic mesothelioma should not be referred to as a benign cystic mesothelioma, as it has potential for locoregional invasion, as well as distant nodal and serosal metastases. This tumour should be treated with aggressive cytoreductive surgery and appropriate chemotherapy. We review the differential diagnosis of this rare entity and suggest guidelines for its differentiation.
INTRODUCTION
Peritoneal mesotheliomas present with varied clinical, pathological and radiological features. Awareness of this may help both oncologists and radiologists narrow down the differential diagnoses and increase the chance of an accurate diagnosis.
Cystic mesothelioma (CM) of the penitoneum is a rare neoplasm that occurs predominantly in women and tends to recur locally.
CM typically arises from the mesothelium of the viscera in the pelvis, but may occur in other areas such as the intraperitoneal and retroperitoneal spaces. (1, 2) To our knowledge, there is a paucity of data in the literature regarding this entity. In this report, we present a case of CM and review the relevant literature on CM.
CASE REPORT
A 34-year-old woman presented with a one-year history of mild right iliac fossa pain. She had no history of vomiting, abdominal distension, change in bladder or bowel habits, or loss of appetite or weight. She gave a history of irregular menstruation for the past two years. Clinical examination revealed a right adnexal mass. Other systemic examinations were within normal limits.
Before the patient presented to our institute, she had attended another hospital where resection of the lesion was planned.
However, intraoperatively, the tumour was found to be unresectable. A biopsy was done, after which she was referred to our institute for further treatment.
Computed tomography (CT) of the abdomen revealed a well-defined lesion with peripheral enhancement, measuring approximately 2 cm, in the right iliac fossa. The lesion involved the free margin of the mesentery and had a peripheral cystic component measuring 8 cm encasing the right ovary (Fig. 1) .
Ultrasonography (US) of the lesion showed a predominantly cystic lesion with multiple loculations encasing the right ovary (Fig. 2) . The possibility of an ovarian malignancy was considered.
Histopathology revealed a tumour that was composed of multiple well-defined cystic spaces separated by a loose and myxoid spindle-celled stroma. The tumour contained scattered inflammatory cells, foci of haemorrhage and fibrin deposition.
The spaces contained pale pink fluid that did not stain well with Periodic-Acid Schiff Diastase (PASD). Some cysts appeared to have no distinct lining, whereas others were rimmed by flattened or plump cells. A few of the cysts were free in the lumen.
The stromal cells had a variable appearance -enlarged and pleomorphic in some areas and relatively uniform elsewhere. Table I . (1) Except for malignant peritoneal mesotheliomas, the other peritoneal mesotheliomas are not related to asbestos exposure.
Pathologically, CM typically consists of multiple grapelike clusters of mesothelium-lined cysts, although it may also be unilocular. (3) The pathognomonic feature of these lesions is a thin-wall cystic structure located within a gelatinous-appearing mass. These thin-walled cysts are of variable size and preferentially located within the greater omentum and pelvis, and beneath the right hemidiaphragm. (4) The major radiological differential diagnoses of CM are cystic lymphangioma, cystic epithelial neoplasm of the ovaries, tuberculosis and endometriosis. (4, 5) Other rare peritoneal neoplasms include primary peritoneal serous carcinoma, leiomyomatosis peritonealis disseminata, and desmoplastic small round cell tumour.
CM is traditionally considered to be a benign neoplasm. (6) However, in recent years, there have been case studies reporting malignant behaviour in these neoplasms. (7, 8) Our case report supports these studies in highlighting the potential malignant behaviour of CMs. The aim of treatment is complete disease eradication, which can be achieved by adopting an aggressive approach, using cytoreductive surgery to remove the viable tumour. (7) The use of chemotherapy, either neoadjuvant or adjuvant, to control microscopic residual disease will help patients with CM to remain symptom-and disease-free over an extended period of time after a single surgical intervention.
Disease eradication in the form of adjuvant chemotherapy, post debulking surgery may prevent the transition of CM into an aggressive and fatal disease. U r inar y bladder U te r us C a s e R e p o r t e78
The risk of recurrence of the tumours is 50%-60%, which is common, as far as malignancies associated with mesotheliomas are concerned. In conclusion, multicystic mesothelioma is a rare malignancy occuring in the abdomen. It has been described as a benign cystic mesothelioma or peritoneal inclusion cysts. Our case report highlights the possible malignant nature of some of these neoplasms, and underscores the importance of surgery, followed by chemotherapy, in patients with this malignant condition. Large follow-up studies are required to further define the malignant potential of these neoplasms. However, in view of the rarity of CM and hence, the lack of studies with a large cohort of patients, individual experience should be highlighted so as to disseminate knowledge about the natural history of cystic CM of the peritoneum. 
